Download document

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Drug discovery wikipedia , lookup

Drug interaction wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Prescription costs wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Bad Pharma wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Theralizumab wikipedia , lookup

Transcript
Organic Chemistry II
202 - DDB - 05
CAM
Aranesp
By Matthew Seidler (0588687)
Winter 2007
John Abbott College
Overview
• Introduction
• What is it?
• History
• Structure/Chemistry
• Benefits/Risks
• Competitors
• Personal Thoughts
Red Blood Cells
•
•
•
Transport oxygen to various parts of the body
• Oxygen = NP, Blood = P
• Need a way to transport oxygen
Divide rapidly
When your body makes fewer RBCs, anemia develops
What exactly is Aranesp?
• Darbepoetin alfa is a synthetic form of
erythropoietin
• Erythropoietin = produced by kidney,
hormone that stimulates RBC production
• Stimulates erythropoiesis (process by which
erythrocytes (RBCs) are produced when
oxygen is low (hypoxia)
• Stimulates bone marrow to produce RBCs
• When is oxygen supply lowered?
• Exercise
• High altitudes, etc
How EPO works
• EPO binds to receptors (EpoR) in bone
marrow to speed up mitosis of cells
responsible for making RBCs
• Oxygen in blood rises, EPO production
slows down
EPO
Amgen, Inc.
• International Biotech company in
California
• The largest independent biotech firm,
15K staff members
• As of 09/06, Amgen had eight FDA
approved drugs (one of which was
Aranesp)
Back to the drug…
• 09/01: approved by FDA for treatment in anemia in patients with
chronic renal failure
• Kidneys secrete erythropoetin, which stimulates RBC
production
• Patients w/ renal failure commonly suffer from anemia (lower
RBC count)
• 06/01: approved by European Medicines Agency for the same
treatments, but also for anemia patients undergoing
chemotherapy
• Chemotherapy affects rapidly dividing cells (I.e. RBCs)
• You therefore need more erythropoetin in order to stimulate RBC
production
Another Use
• Patients who require a blood transfusion
or have surgery where blood loss is
expected, EPO is given in advance
• If blood is lost in surgery…
How is it made?
• Produced by recombinant DNA technology in
modified Chinese hamster ovary cells
• Differs from real erythropoietin (EPO) in that it
has two more N-linked oligosaccharide
chains
• Why not just use real EPO?
Chemistry of the drug
• C815H1317N233O241S5
• Ok, let’s draw it. IHD = 1/2(2*815+2…)
• Molar mass = 18396.1 g/mol
Anemic Cancer Patients
• 01/07, Amgen wrote a letter that
highlighted the results from a recent
anemia of cancer trial, and warned
doctors
• They informed the FDA that control over
the cancer was worse in patients on
Aranesp (against those who weren’t on
the drug)
What did the FDA say?
• Released a public health advisory, in March
07, and a clinical alert for doctors about the
use of erythropoeisis-stimulating agents such
as epogen and darbepoeitin
• Use caution when using these drugs in
cancer patients
• Lack of clinical evidence to support
improvements in these situations
Risks
• Increases the risk of…
• Cardiovascular problems (RBCs increases
viscocity of blood)
•
•
•
•
•
•
•
•
•
Strokes
Hypertension
Congestive heart failure
Myocardial infarction (heart attack)
Hypertension
Seizures (why?)
Vascular thrombosis (clot inside blood vessel)
Edema (fluid collecting in cavities of body) (why?)
Side effects = fever, chest pains, nausea, etc
$10 000/ yr for drug (dialysis
patient)
$12 000/ yr for drug (chemo
patient)
Sales: $10 B in 2004
Abuse
• Cross country skiers Larisa Lazutina &
Olga Danilova of Russia and Johann
Muhlegg of Spain
EPO as a blood doping agent
• Used by healthy athletes to give a
competitive advantage
• Increases oxygen carrying capacity of
the blood
• Therefore, increases aerobic respiratory
capacity of the muscles
• Helps make more ATP
Continued
• Useful for bicycle races (offsets
decrease in RBC count that occurs over
several races)
• What happens if you OD?
• The drug can produce so many RBCs that
the blood thickens and strains the heart
(I.e. during sleep when HR is low)
Competitors
• From Amgen: Epogen & Aranesp
(Brand names)
• There’s also Dynepo
Dynepo
• Pharmaceutical EPO under
development by Shire Pharmaceuticals
• Launched in Europe in 2006
• Amgen patents prevent it from
launching here
• Instead of being made from cultured
animal cells, it’s made from cultured
human cells
Dynepo
• Has a true form of sialic acid &
oligosaccharide residues
• This makes it longer lasting than
Amgen’s products (this is not confirmed
yet…)
• Undetectible in urine tests for EPO that
is used on athletes
Personal Thoughts
• Jehova’s Witnesses
• Drug can be used for many things
QUESTIONS?